The President of the Parliament of Catalonia, Josep Rull i Andreu, visits the global headquarters of Towa International

• The Rt. Hon. Mr. Josep Rull i Andreu met with the executive team of Towa International and visited the company’s production plant in Barcelona

• During the meeting, the strategic role of Catalonia as a pharmaceutical hub in Europe was highlighted

Barcelona, July 28, 2025. The President of the Parliament of Catalonia, Josep Rull i Andreu, visited the headquarters of Towa International, the international hub of Towa Pharmaceutical, a leading company in the generic medicines market in Japan. During the visit, President Rull met with the company’s executive team and toured the production plant, equipped with state-of-the-art technology.

In the meeting, the shared commitment to continue strengthening Catalonia’s healthcare ecosystem as an international benchmark was emphasized, along with the importance of fostering collaboration between the public and private sectors.

The President of the Parliament of Catalonia, Josep Rull i Andreu, stated: “Towa International’s commitment to research, innovation, and the development of generic medicines contributes, from Catalonia, to global health.”

“It was an honor to share our vision with the President of the Parliament of Catalonia and his cabinet. We firmly believe in Catalonia’s potential as a European engine in the pharmaceutical sector. Five years ago, Towa Pharmaceutical chose Barcelona for its competitive advantages: a first-class ecosystem, universities generating talent, and advanced infrastructure. At Towa International, we work every day with the purpose of contributing to people’s health from here, with the goal of reaching the greatest number of patients worldwide,” emphasized David Peix, CEO of Towa International.

Catalonia is consolidating its position as one of the main drivers of innovation, economic development, and social progress in the European pharmaceutical sector. Towa International is the only Japanese international hub with a presence in Catalonia, thus reinforcing the strategic positioning of the region globally.

Towa International is dedicated to the research, development, manufacturing, and distribution of generic medicines, with a production capacity of over 6 billion units per year from its facilities in Martorelles, Barcelona. From there, the company coordinates its global operations with a direct presence in Spain, Italy, Portugal, and the United States, and has an indirect presence in over 40 countries through its company Towa2B.